Celltrion chairman\

Proxy advisory firm International Shareholder Services (ISS) has expressed its support for all of Kumho Petrochemical Co.'s proposals up for vote ...

Chung Yong-jin, vice chairman of South Korea’s retail giant Shinsegae Group, has been promoted to chairman to strengthen his clout over the co...

South Korea's Celltrion Inc. announced on Wednesday that it shipped the first supply of its subcutaneous injection type of the autoimmune disease tr...

Mark Zuckerberg, chief executive of US tech giant Meta Platforms Inc. plans to visit South Korea later this month and meet key figures including Pre...

Park Chul-whan, the nephew of Kumho Petrochemical Co.'s former Chairman Park Chan-koo, has launched a proxy fight jointly with an activist fund, fue...

South Korea’s Celltrion Inc. announced on Thursday that it will supply three treatments, including its blood cancer drug Truxima (rituximab) t...

The chairman nominee of POSCO Holdings Inc., the parent of the world’s No. 7 steelmaker POSCO, is expected to concentrate on improving its cor...

POSCO Holdings Inc., the parent of South Korea’s largest steelmaker POSCO, has nominated former President Chang In-hwa as its next group chair...

South Korea's Celltrion Inc. announced on Wednesday that it will supply its autoimmune disease treatments Remsima SC (infliximab) and Yuflyma, the...

SK Networks Co., a South Korean trading company, joined hands with Silicon Valley-based venture capital firm Bow Capital for investment cooperation,...

Lotte Group plans to sell ailing units as the South Korean retail-to-chemical conglomerate is shifting its focus to new growth sectors such as bio, ...

South Korea’s Celltrion Inc. has signed a business agreement with China’s WuXi XDC to jointly develop new antibody-drug conjugates (ADC)...

The Korea Financial Investment Association (KOFIA) will go all out to minimize any adverse effects on the South Korean financial market from an anti...

Woori Financial Group, South Korea’s fourth-largest financial holding company, will reinforce its wealth management service for high-net-worth...

South Korea’s Celltrion Inc. announced on Thursday that it has secured supply contracts for three anticancer biosimilars in European countries...

South Korean biosimilar giant Celltrion Group is planning to debut on the Nasdaq market by early 2025, founder and Chairman Seo Jung-jin said at the...

Merging into one team, OCI Group and Hanmi Pharmaceutical Group will leap forward to be a global novel drug manufacturing and biotechnology innova...

South Korea’s Celltrion Inc. announced on Friday that it will supply its biosimilar Yuflyma (active ingredient: adalimumab) for the treatment ...

Celltrion Inc., South Korea's leading biosimilar maker, on Wednesday expressed its ambition to join the global top 10 biotech and pharmaceutical com...

The heirs of late Samsung Group Chairman Lee Kun-hee are seeking to sell their shares in Samsung Electronics Co. and other Samsung affiliates worth ...

South Korea's Celltrion Inc. announced on Wednesday that it has applied to the US Food and Drug Administration (FDA) for a modified approval to repl...

POSCO Holdings Inc.'s Chairman Choi Jeong-woo is not among the company’s next CEO candidates, suggesting Choi will leave the company after ser...

MBK Partners said on Wednesday it has named Moon Joo Ho, partner and head of South Korea for special situations, as the North Asia-focused private e...

South Korea’s Celltrion Inc. will divest of a portfolio of Takeda Pharmaceutical's prescription medicines sold in Asia to CBC Group, a Singapo...

South Korean biopharmaceutical company Celltrion Inc. announced on Wednesday that it has applied for CT-P39, a biosimilar of the treatment of asth...

The global semiconductor market has hit "rock bottom" but uncertainties remain high amid growing protectionism and lingering concerns about China&rs...

South Korea’s Booyoung Group donated 600 buses to Laos. According to the group on Thursday, the Chairman of Booyoung Group Lee Joong-Keun, an...

Cho Hyun-bum, chairman of Hankook & Company Co., the holding firm of South Korea’s top tire maker Hankook Tire & Technology Co., said ...

South Korea's Celltrion Healthcare Co. announced on Tuesday that its anti-cancer biosimilar Vegzelma (active ingredient: bevacizumab) was listed as ...

SK Group is setting out for a new era, tapping younger leaders in their 40s and 50s to lead South Korea’s second-largest group in its mission ...